Enanta Pharmaceuticals
ENTA
#7678
Rank
A$0.55 B
Marketcap
A$19.23
Share price
-1.53%
Change (1 day)
135.35%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: A$0.55 Billion

As of January 2026 Enanta Pharmaceuticals has a market cap of A$0.55 Billion. This makes Enanta Pharmaceuticals the world's 7678th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.55 B-23.55%
2025A$0.72 B254.56%
2024A$0.20 B-29.59%
2023A$0.29 B-79.54%
2022A$1.42 B-32.78%
2021A$2.11 B92.39%
2020A$1.09 B-37.11%
2019A$1.74 B-10.54%
2018A$1.95 B35.93%
2017A$1.43 B62.46%
2016A$0.88 B3.87%
2015A$0.85 B-26.34%
2014A$1.15 B110.48%
2013A$0.54 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

A$0.55 Billion
by Nasdaq info icon info icon
A$0.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
A$579.37 B 104,268.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$752.76 B 135,502.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$175.93 B 31,592.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$406.31 B 73,094.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$169.14 B 30,369.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$405.40 B 72,930.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland